Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | FGL2 |
| Upstream (Parents) |
|---|
| (<<) MS4A6A → FGL2 |
| (<<) PTPRC → FGL2 |
| (<<) HLA-DPA1 → FGL2 |
| (<<) PTGER4 → FGL2 |
| (<<) DOCK2 → FGL2 |
| Downstream (Children) |
|---|
| FGL2 → GPR65 (>>) |
| FGL2 → MS4A6A (>>) |
| FGL2 → MUC2 (>>) |
| FGL2 → LILRB2 (>>) |
| FGL2 → NCF1C///NCF1B///NCF1 (>>) |
| FGL2 → C17orf60 (>>) |
| FGL2 → CCL8 (>>) |
| FGL2 → GLIPR1 (>>) |
| FGL2 → ANKRD1 (>>) |
| FGL2 → CD86 (>>) |
| FGL2 → SLA (>>) |
| FGL2 → BTN3A3 (>>) |
| FGL2 → GIMAP4 (>>) |
| FGL2 → CTSC (>>) |
| FGL2 → CCL4 (>>) |
| FGL2 → IL18R1 (>>) |
| FGL2 → MRC1L1///MRC1 (>>) |
| FGL2 → PLEK (>>) |
| FGL2 → INPP5D (>>) |
